Latest News
Texas court tosses state Vioxx suit against Merck
Reuters | 13 hours 42 minutes ago
NEW YORK (Reuters) - A Texas court has dismissed a lawsuit brought by the state against drugmaker Merck & Co that sought a refund for money spent on the withdrawn Vioxx pain treatment, the company said on Monday.... (more)
Raptor's genetic disorder drug meets study goals
Miami Herald, The | 13 hours 43 minutes ago
NOVATO, Calif. -- Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.... (more)
Pfizer, Immunovaccine in animal vaccine deal
Miami Herald, The | 13 hours 44 minutes ago
NEW YORK -- Immunovaccine Inc. said Monday that Pfizer Inc., the world's largest drugmaker, is licensing its technology for use in vaccines for cattle.... (more)
Cel-Sci Chairman Sells Stock, Despite Sweetheart Loan Deal: BioBuzz
TheStreet.com | 13 hours 45 minutes ago
VIENNA, Va. (TheStreet) -- Cel-Sci(CVM Quote) founder and chairman Maximilian de Clara sold nearly one quarter of his common stock holdings in the company, according to a late Friday filing with the Securities and Exchange Commission.... (more)
Pfizer, Immunovaccine will collaborate on cattle vaccines; terms of partnership not disclosed
Sun (Baltimore), The | 13 hours 45 minutes ago
Immunovaccine Inc. said Monday that Pfizer Inc., the world's largest drugmaker, is licensing its technology for use in vaccines for cattle.... (more)
Bristol-Myers extends partnership with Asterand
Philadelphia Inquirer, The | 14 hours 7 minutes ago
NEW YORK - Drugmaker Bristol-Myers Squibb Co. and Asterand PLC are extending a research collaboration for up to three years, Asterand said Monday.... (more)
Raptor Pharmaceutical's genetic disorder drug meets midstage study goals
Star Tribune (Minneapolis-St. Paul, Minn.) | 14 hours 13 minutes ago
NOVATO, Calif. - Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.... (more)
Seattle Genetics gets $12 million in Astellas deal
Washington Post, The | 14 hours 15 minutes ago
BOTHELL, Wash. -- Seattle Genetics Inc. said Monday it will receive $12 million as part of an expanded collaboration with Astellas unit Agensys Inc. ... (more)
Seattle Genetics receives $12 million in expansion of partnership with Astellas
Star Tribune (Minneapolis-St. Paul, Minn.) | 14 hours 16 minutes ago
BOTHELL, Wash. - Seattle Genetics Inc. said Monday it will receive $12 million as part of an expanded collaboration with Astellas unit Agensys Inc.... (more)
Asterand says Bristol-Myers Squibb extends research partnership for 3 more years
Star Tribune (Minneapolis-St. Paul, Minn.) | 14 hours 16 minutes ago
NEW YORK - Drugmaker Bristol-Myers Squibb Co. and Asterand PLC are extending a research collaboration for up to three years, Asterand said Monday.... (more)
Pfizer receives approval for expanded use of Geodon
Drug Store News | 14 hours 19 minutes ago
By Alaric DeArmentNEW YORK (Nov. 23) The Food and Drug Administration has approved a new use for a bipolar disorder and schizophrenia drug made by Pfizer.... (more)
Spray can prevent premature ejaculation: study
Yahoo! | 14 hours 56 minutes ago
WASHINGTON (Reuters) ? A spray that numbs the penis can help prevent premature ejaculation, doctors reported on Thursday, and drug maker Sciele Pharma Inc, a division of Japan's Shionogi, plans to file for U.S. approval next year.... (more)
255 Stories | 
RSS Feed
Sign up for BIO SmartBrief
Latest Blog Postsview more
it certification
Science Blog
Passforsure F5 Networks F50-515 examination
Science Blog
Passforsure F5 Networks F50-515 examination
Science Blog
it certification
Science Blog
Companies in the news
- Abraxis Bioscience Inc
- Biogen IDEC Inc.
- Biomarin Pharmaceutical
- Boehringer Ingelheim
- Dendreon Corp
- Fluidigm Corp.
- GlaxoSmithKline plc
- IVAX
- Johnson & Johnson
- La Jolla Pharmaceutical
- Merck & Co.
- Merck Serono
- Nabi Biopharmaceuticals
- Novartis
- Progenics Pharmaceutical